https://www.galderma.com/ 2026-03-04T13:31:02+00:00 daily 1.0 https://www.galderma.com/galderma-advancing-dermatology-every-skin-story 2026-03-04T13:31:02+00:00 0.5 https://www.galderma.com/contact-us 2025-11-19T13:44:08+00:00 0.5 https://www.galderma.com/stories 2026-03-03T16:24:55+00:00 0.5 https://www.galderma.com/our-brands 2026-01-27T10:24:03+00:00 0.5 https://www.galderma.com/newsroom 2022-11-14T15:27:05+00:00 0.5 https://www.galderma.com/sitemap 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/about-us 2026-03-05T07:34:53+00:00 0.5 https://www.galderma.com/glance 2026-03-10T11:02:04+00:00 0.5 https://www.galderma.com/innovation 2025-03-27T14:35:25+00:00 0.5 https://www.galderma.com/language-selector 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/global-presence 2024-02-27T13:38:24+00:00 0.5 https://www.galderma.com/our-purpose 2026-03-04T15:18:41+00:00 0.5 https://www.galderma.com/executive-committee 2026-01-30T10:05:56+00:00 0.5 https://www.galderma.com/neil-popplewell 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/bringing-innovation-life 2026-03-05T11:17:09+00:00 0.5 https://www.galderma.com/partnering 2026-03-04T17:21:33+00:00 0.5 https://www.galderma.com/sustainability 2026-03-06T09:40:27+00:00 0.5 https://www.galderma.com/manufacturing 2026-03-10T13:33:58+00:00 0.5 https://www.galderma.com/restylane 2021-03-25T14:20:05+00:00 0.5 https://www.galderma.com/sculptra 2021-03-31T14:28:34+00:00 0.5 https://www.galderma.com/azzalure 2021-09-14T13:15:05+00:00 0.5 https://www.galderma.com/dysport 2021-09-14T13:15:53+00:00 0.5 https://www.galderma.com/cetaphil 2021-03-31T10:51:18+00:00 0.5 https://www.galderma.com/social-responsibility 2023-06-12T12:21:50+00:00 0.5 https://www.galderma.com/funding-request-for-education-and-support-activities 2024-03-25T02:10:23+00:00 0.5 https://www.galderma.com/governance-oversight 2025-09-17T10:10:54+00:00 0.5 https://www.galderma.com/dermatological-skincare 2026-03-05T07:57:34+00:00 0.5 https://www.galderma.com/therapeutic-dermatology 2026-03-05T07:58:33+00:00 0.5 https://www.galderma.com/galderma-aesthetics 2026-03-05T07:24:10+00:00 0.5 https://www.galderma.com/transparency-reports-2015 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/transparency-reports-2016 2024-07-03T07:53:52+00:00 0.5 https://www.galderma.com/austria 2026-02-26T15:27:18+00:00 0.5 https://www.galderma.com/finland 2025-04-29T10:35:02+00:00 0.5 https://www.galderma.com/denmark 2025-04-29T10:38:21+00:00 0.5 https://www.galderma.com/norway 2025-04-29T10:26:49+00:00 0.5 https://www.galderma.com/italy 2026-03-20T15:20:03+00:00 0.5 https://www.galderma.com/canada 2026-02-17T10:35:28+00:00 0.5 https://www.galderma.com/argentina 2024-02-12T00:47:05+00:00 0.5 https://www.galderma.com/chile 2025-08-27T19:38:47+00:00 0.5 https://www.galderma.com/benelux 2021-03-31T14:21:47+00:00 0.5 https://www.galderma.com/singapore 2026-04-01T16:42:06+00:00 0.5 https://www.galderma.com/transparency-reports-2017 2024-06-27T12:21:34+00:00 0.5 https://www.galderma.com/thailand 2021-03-24T13:35:17+00:00 0.5 https://www.galderma.com/poland 2024-12-18T13:57:59+00:00 0.5 https://www.galderma.com/switzerland 2026-02-26T15:29:48+00:00 0.5 https://www.galderma.com/suisse 2025-11-13T12:33:52+00:00 0.5 https://www.galderma.com/slovakia 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/czech-republic 2022-10-10T11:58:11+00:00 0.5 https://www.galderma.com/south-africa 2024-04-03T09:30:29+00:00 0.5 https://www.galderma.com/mainland-china 2022-12-08T12:04:49+00:00 0.5 https://www.galderma.com/transparency-reports-2018 2024-06-27T16:40:05+00:00 0.5 https://www.galderma.com/thomas-dittrich 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/flemming-ornskov-md-mph 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/our-response-coronavirus-pandemic 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/fraser-halscheid 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/transparency-reports-2019 2024-06-27T16:43:52+00:00 0.5 https://www.galderma.com/job-search 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/job-share 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/agent-delete 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/agent 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/job-details 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/apply 2021-06-28T07:37:45+00:00 0.5 https://www.galderma.com/kristen-slaoui 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/christian-marcoux 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/hong-kongmacau-china 2026-03-05T12:50:19+00:00 0.5 https://www.galderma.com/your-data 2024-12-20T13:30:19+00:00 0.5 https://www.galderma.com/terms-use 2024-11-28T15:47:52+00:00 0.5 https://www.galderma.com/restylane-0 2021-03-30T13:06:12+00:00 0.5 https://www.galderma.com/transparency-reports-2020 2021-06-28T12:47:53+00:00 0.5 https://www.galderma.com/skin-science 2024-10-03T14:40:54+00:00 0.5 https://www.galderma.com/transparency-reports-2021 2024-06-30T19:31:34+00:00 0.5 https://www.galderma.com/annual-review-2021 2023-02-07T19:20:58+00:00 0.5 https://www.galderma.com/our-strategy 2026-03-05T10:58:39+00:00 0.5 https://www.galderma.com/our-employees 2026-03-05T11:02:45+00:00 0.5 https://www.galderma.com/patients-and-consumers 2026-03-06T11:36:22+00:00 0.5 https://www.galderma.com/healthcare-professionals-and-customers 2026-03-05T11:09:12+00:00 0.5 https://www.galderma.com/our-position-early-access 2024-02-28T12:20:16+00:00 0.0 https://www.galderma.com/intentiontofloat 2024-03-26T19:24:46+00:00 0.5 https://www.galderma.com/newsroom-new 2026-03-05T06:16:05+00:00 0.5 https://www.galderma.com/news-archive 2022-12-21T14:10:34+00:00 0.5 https://www.galderma.com/governance 2026-03-04T15:20:08+00:00 0.5 https://www.galderma.com/adrian-murphy 2024-03-01T13:45:23+00:00 0.5 https://www.galderma.com/sweden 2025-04-29T10:22:08+00:00 0.5 https://www.galderma.com/es-es/politica-privacidad-farmacovigilancia 2023-07-05T15:11:14+00:00 0.5 https://www.galderma.com/es-es/terminos-y-condiciones 2023-07-05T15:10:35+00:00 0.5 https://www.galderma.com/pt-pt/politica-de-privacidade 2023-08-18T08:37:32+00:00 0.5 https://www.galderma.com/pt-pt/termos-e-condicoes 2023-07-05T15:06:43+00:00 0.5 https://www.galderma.com/es-es/pol%C3%ADtica-de-privacidad 2023-08-17T11:37:31+00:00 0.5 https://www.galderma.com/transparency-report-2022 2024-01-15T18:02:15+00:00 0.5 https://www.galderma.com/pt-pt/politica-de-privacidade-farmacovigilancia 2023-07-05T15:06:06+00:00 0.5 https://www.galderma.com/fr-fr/politique-de-vigilance 2023-07-26T09:43:34+00:00 0.5 https://www.galderma.com/fr-fr/mentions/legales 2023-07-26T10:35:18+00:00 0.5 https://www.galderma.com/fr-fr/politique-des-donnees-personnelles 2023-07-26T10:35:58+00:00 0.5 https://www.galderma.com/annual-review-2022 2024-02-13T11:48:56+00:00 0.5 https://www.galderma.com/cookie-policy 2025-02-13T13:44:59+00:00 0.5 https://www.galderma.com/fr-fr/politique-relative-aux-cookies 2025-02-13T13:44:59+00:00 0.5 https://www.galderma.com/es-es/politica-de-cookies 2025-02-13T13:44:59+00:00 0.5 https://www.galderma.com/de-de/cookie-richtlinie 2025-02-13T13:44:59+00:00 0.5 https://www.galderma.com/it/informativa-sui-cookie 2025-02-13T13:44:59+00:00 0.5 https://www.galderma.com/se-se/cookiepolicy 2025-02-13T13:44:59+00:00 0.5 https://www.galderma.com/pt-pt/politica-de-cookies 2023-07-05T15:05:12+00:00 0.5 https://www.galderma.com/media-toolkit-atopic-dermatitis-prurigo-nodularis 2024-12-11T13:41:14+00:00 0.5 https://www.galderma.com/our-esg-index 2026-03-05T07:12:22+00:00 0.5 https://www.galderma.com/es-es/terminos-y-condiciones-generales-de-venta 2025-07-10T10:46:10+00:00 0.5 https://www.galderma.com/careers 2026-03-20T10:43:20+00:00 0.5 https://www.galderma.com/next-galderma 2024-02-07T17:12:33+00:00 0.5 https://www.galderma.com/annual-review-2023 2025-03-14T09:46:24+00:00 0.5 https://www.galderma.com/foreword-ceo-2023 2024-03-15T09:05:37+00:00 0.5 https://www.galderma.com/ru-ru/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%BD%D0%B0%D0%B4%D0%B7%D0%BE%D1%80-%D0%B8-%D0%BA%D0%B0%D1%87%D0%B5%D1%81%D1%82%D0%B2%D0%BE 2024-07-29T10:44:04+00:00 0.5 https://www.galderma.com/ru-ru/politika-v-otnoshenii-faylov-cookie 2024-07-29T12:49:16+00:00 0.5 https://www.galderma.com/ru-ru/privacy 2024-07-29T10:44:01+00:00 0.5 https://www.galderma.com/ru-ru/terms-of-use 2024-07-29T10:55:29+00:00 0.5 https://www.galderma.com/ru-ru/policy 2024-07-29T10:43:56+00:00 0.5 https://www.galderma.com/news-archive/key-release 2024-03-21T10:04:32+00:00 0.5 https://www.galderma.com/news-archive/us-release 2024-03-21T10:04:16+00:00 0.5 https://www.galderma.com/news-archive/global-release 2024-03-21T10:03:58+00:00 0.5 https://www.galderma.com/transparency-report-2023 2024-07-01T21:47:51+00:00 0.5 https://www.galderma.com/media-toolkit-atopic-dermatitis 2024-12-13T21:14:20+00:00 0.5 https://www.galderma.com/media-toolkit-prurigo-nodularis 2024-12-12T08:36:54+00:00 0.5 https://www.galderma.com/poland/Twoje-dane 2025-05-30T16:41:32+00:00 0.5 https://www.galderma.com/poland/cookies 2024-07-27T19:11:59+00:00 0.5 https://www.galderma.com/beauty-x-medicine 2025-10-22T12:35:21+00:00 0.5 https://www.galderma.com/transparency-report-2024 2025-07-03T13:36:19+00:00 0.5 https://www.galderma.com/podcast 2025-02-10T12:53:28+00:00 0.5 https://www.galderma.com/skin-stories 2026-03-04T15:14:45+00:00 0.5 https://www.galderma.com/annual-report-2024 2026-01-07T12:43:50+00:00 0.5 https://www.galderma.com/br-pt/politica-de-privacidade 2025-05-29T10:23:24+00:00 0.5 https://www.galderma.com/br-pt/termos-e-condicoes 2025-05-29T10:23:35+00:00 0.5 https://www.galderma.com/br-pt/politica-de-cookies 2025-05-29T10:23:54+00:00 0.5 https://www.galderma.com/medical-community-support 2025-08-01T17:17:44+00:00 0.5 https://www.galderma.com/medication-driven-weight-loss 2025-07-30T09:07:50+00:00 0.5 https://www.galderma.com/website-standards 2025-08-15T18:41:27+00:00 0.5 https://www.galderma.com/fr-fr/politique-de-confidentialite-information-promotionnelle-professionnels-de-sante 2025-12-16T01:40:48+00:00 0.5 https://www.galderma.com/se-se/terms-use 2025-11-14T10:44:55+00:00 0.5 https://www.galderma.com/se-se/galderma-nordic-integritetsmeddelande 2025-11-14T10:46:30+00:00 0.5 https://www.galderma.com/annual-report-2025 2026-03-05T06:35:27+00:00 0.5 https://www.galderma.com/nakisa-serry 2026-01-30T10:05:32+00:00 0.5 https://www.galderma.com/your-data/privacy-notice-canada-EN 2026-02-16T20:26:41+00:00 0.5 https://www.galderma.com/your-data/privacy-notice-canada-FR 2026-02-16T20:29:26+00:00 0.5 https://www.galderma.com/switzerland/terms-and-conditions 2026-02-26T15:30:49+00:00 0.5 https://www.galderma.com/austria/terms-and-conditions 2026-02-26T15:28:59+00:00 0.5 https://www.galderma.com/news/cetaphil-celebrates-70-years-healthy-skin 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/aging-experts-join-nestle-skin-health-iagg-2017-shine-spotlight-skin-health-critical-pathway 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-enrollment-first-patient-phase-iib-nemolizumab-trial-atopic-dermatitis 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/stuart-raetzman-appointed-ceo-nestle-skin-health 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-releases-itch-application-itch-tracker-apple-watch-and-researchkit 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-shield-hackathon-inspires-winning-innovations-skin-health 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/appointment-nestle-skin-health-ceo-ad-interim 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/four-female-founders-share-candid-insights-building-successful-business-health-technology 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-honored-american-federation-aging-research 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/pinetree-care-group-and-nestle-skin-health-join-forces-pilot-study-improve-skin-health-among 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/leadership-change 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-receives-positive-opinion-through-european-decentralised-procedure-approval-epiduor 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-and-chugai-announce-global-license-agreement-nemolizumab-novel-biotherapy-skin 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/fda-approves-galdermas-prescription-strength-differin-gel-over-counter-use-treatment-acne-us 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galdermas-epiduo-gel-approved-treatment-acne-japan 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-trifarotene-development-program-meets-key-milestone-lamellar-ichthyosis-orphan 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-shield-receives-corporate-leadership-award-american-skin-association 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-form-non-prescription-acne-joint-venture-guthy-renker 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/atp-and-nestle-skin-healths-daylong-announce-exclusive-global-sun-care-partnership 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-appoints-dr-johannes-j-baensch-chief-scientific-officer 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-invests-46-million-factory-extension-canada 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-promotes-life-course-healthy-skin-and-provides-new-educational-tools-during 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-builds-chf-54-million-factory-brazil 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-launches-shield-center-shanghai-enable-and-advance-healthy-and-active 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-acquire-inneov-assets 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-announces-leadership-team 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-open-global-network-innovation-hubs-advance-next-generation-skin-health 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/global-cross-sector-leaders-unite-commit-life-course-healthy-skin-global-partnership 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-initiates-us-study-novel-muscle-relaxant-aesthetic-dermatology-and-cosmetic-surgery 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-acquisition-loreals-50-stake-galderma-completed 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-acquire-aesthetic-dermatology-assets-nestle-skin-health 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-sa 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-announces-its-intention-cease-operations-its-egerkingen-factory 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nestle-invests-chf-150-million-two-new-factories 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/fda-approval-restylaner-lyft-hands 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/collaboration-between-janssens-and-galdermas-nordic-affiliates 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/new-extended-deadline-2018-galderma-skinpact-awards-focus-north-america 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-global-study-reveals-true-burden-rosacea-and-encourages-healthcare-professionals-look 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-and-maruho-release-renewed-itch-measurement-app-itch-tracker-apple-watch 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/shionogi-and-galderma-announce-memorandum-understanding-adapalene 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/global-corporate-campaign-awarded-medical-marketing-association 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/fda-approves-differin-adapalene-gel-03-acne 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/new-galderma-quality-report-reveals-new-trends-dermatology 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/ipsen-and-galderma-agreement-dysport-brazil-argentina-paraguay 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-reaches-agreement-acquire-collagenex-pharmaceuticals 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/agreement-extension-cover-worldwide-rights-pliaglis-r 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-completes-tender-offer-collagenex 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-completes-acquisition-collagenex 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-approval-differin-r-gel-01-japan 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-availability-epiduo-tm-gel-usa 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/health-authorities-15-european-countries-give-collective-green-light-azzalure-r 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-wins-fda-approval-vectical-tm-ointment 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/azzalure-r-approved-uk-aesthetic-use-treatment-glabellar-lines 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/azzalure-r-approved-france-aesthetic-use-treatment-frown-lines 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/azzalure-r-approved-germany-aesthetic-use-treatment-glabellar-lines 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/azzalure-r-approved-spain-aesthetic-use-treatment-glabellar-lines 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-received-fda-approval-differinr-adapalene-lotion-01-first-retinoid-available-lotion 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/cetaphilr-brand-launches-cetaphilr-restoradermr-new-line-products-help 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-results-largest-ever-rosacea-trial 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-launches-emervelr-range-hyaluronic-acid-dermal-fillers 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/astrazeneca-and-galderma-enter-rd-collaboration-develop-new-treatments-dermatological-diseases 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-positive-us-pivotal-interim-6-month-results-emervel-classic-lidocaine 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-positive-phase-2b-results-investigational-compound-targeting-redness 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-availability-new-metrogel-1-pump-dispenser-treatment-papulopustular-rosacea 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval-new-convenient-pump-dispenser-differin-gel-03-treatment-acne 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-announces-completion-phase-3-trials-investigational-drug-targeting-facial-erythema 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/q-med-discontinues-breast-indication-macrolane 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-and-novabay-enroll-first-patients-phase-2b-clinical-study-nvc-422-impetigo 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/ipsen-and-galderma-increase-their-collaboration-dysportr-new-territories 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-worlds-leading-company-focused-exclusively-dermatology-acquires-spirig 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/nuvo-research-announces-european-launch-pliaglisr-galderma 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/american-academy-dermatology-and-galderma-announce-new-innovative-research-fellowship 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-initiates-clinical-development-novel-muscle-relaxant 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval-mirvasor 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/jeannette-r-jakus-md-mba-awarded-american-academy-dermatology-translational-biotechnology 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/experts-call-improved-identification-high-burden-rosacea-patients-everyday-practice 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/women-focused-biotech-takes-top-prize-nestle-skin-health-shield-pitch-event 2020-10-27T10:08:48+00:00 0.5 https://www.galderma.com/news/galderma-us-initiates-six-new-studies-increasing-companys-commitment-aesthetic-research-and 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-announces-positive-results-phase-2b-study-nemolizumab-patients-moderate-severe-atopic 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/international-dermatology-community-voting-2018-galderma-skinpact-awards 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-opens-office-malaysia 2022-11-03T08:46:13+00:00 0.5 https://www.galderma.com/news/galderma-announces-formation-women-aesthetics-leadership-council 2022-12-12T14:28:18+00:00 0.5 https://www.galderma.com/news/galderma-new-data-reveals-benefits-combining-oral-and-topical-treatment-patients-severe 2022-11-03T08:47:39+00:00 0.5 https://www.galderma.com/news/galderma-announces-publication-pivotal-phase-3-perfect-1-and-perfect-2-clinical-trials 2022-11-03T08:47:11+00:00 0.5 https://www.galderma.com/news/galderma-presented-final-results-phase-2b-study-nemolizumab-patients-moderate-severe-atopic 2022-11-03T08:48:12+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-shield-hosts-skin-microbiome-summit 2022-11-03T08:48:45+00:00 0.5 https://www.galderma.com/news/galderma-marks-rosacea-awareness-month-new-insights-why-some-patients-are-self-treating-and 2022-11-03T08:49:43+00:00 0.5 https://www.galderma.com/news/galdermas-azzalure-and-dysportr-celebrate-decade-treatment-glabellar-lines 2022-11-03T08:49:15+00:00 0.5 https://www.galderma.com/news/nestle-enters-exclusive-negotiations-sell-nestle-skin-health-consortium-led-eqt-and-adia 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/launch-skin-science-foundation 2022-11-03T08:50:41+00:00 0.5 https://www.galderma.com/news/galderma-become-worlds-largest-independent-global-dermatology-company-after-completion-chf-102 2022-12-12T14:27:23+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval-akliefr-trifarotene-cream-0005-first-new-retinoid-molecule 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-announces-positive-phase-2-results-its-proprietary-liquid-formulation-investigational 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-advances-phase-3-clinical-study-nemolizumab-moderate-severe-atopic-dermatitis 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/face-rosacea-galderma-launches-new-campaign-empower-and-equip-rosacea-patients-discuss-true 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-demonstrates-robust-aesthetic-innovation-pipeline-initiation-seven-new-clinical 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-investigational-therapy-nemolizumab-granted-fda-breakthrough-therapy-designation 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-receives-positive-outcome-through-european-decentralised-procedure-akliefr 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-announces-new-england-journal-medicine-publication-phase-2-study-investigational 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-demonstrates-continued-commitment-aesthetic-education-offering-new-series-digital 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-receives-approval-restylaner-vitaltm-restylaner-lyfttm-and-restylaner-lidocaine-china 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/cetaphil-galderma-unites-forces-focus-hand-health-and-safety-their-good-hands-initiative-fight 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-closes-sale-bubchen-dallmanns-pharma 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval-restylaner-kysse-new-hyaluronic-acid-ha-filler-specifically 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-announces-top-line-results-clinical-study-showing-patients-treated-dysportr 2022-11-02T16:40:18+00:00 0.5 https://www.galderma.com/news/galderma-global-research-reveals-struggles-people-rosacea-and-psoriasis-face-experiencing-lack 2022-11-02T16:25:07+00:00 0.5 https://www.galderma.com/news/galderma-present-five-abstracts-support-novel-aesthetics-solutions-and-pipeline-asds-2020 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-announces-top-line-results-phase-2-clinical-dose-escalating-study-azzalurer-dysportr 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-launches-dysportr-china-treatment-glabellar-lines 2025-11-19T11:29:06+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval-restylaner-defyne-chin-augmentation 2022-12-12T14:22:47+00:00 0.5 https://www.galderma.com/news/unveiling-new-galderma 2022-10-20T08:52:59+00:00 0.5 https://www.galderma.com/news/galderma-announces-publication-phase-2b-trial-results-demonstrating-rapid-and-long-lasting 2022-10-20T08:52:29+00:00 0.5 https://www.galderma.com/news/galderma-online-survey-reveals-almost-two-thirds-rosacea-patients-are-experiencing-worsening 2022-10-20T08:53:32+00:00 0.5 https://www.galderma.com/news/galderma-continues-global-growth-ambition-sculptrar-injectable-poly-l-lactic-acid-re-launch 2022-11-02T15:11:09+00:00 0.5 https://www.galderma.com/news/rosaceaunmasked-galderma-unites-rosacea-community-shine-light-impact-essential-covid-19-mask-0 2022-10-19T15:26:23+00:00 0.5 https://www.galderma.com/news/galderma-acts-workplace-health-and-safety-0 2022-10-19T15:43:33+00:00 0.5 https://www.galderma.com/news/galderma-launches-new-multichannel-medical-education-platform-inaugural-webinar-series-2 2022-10-19T15:43:00+00:00 0.5 https://www.galderma.com/news/new-study-reveals-impact-hidden-acne-quality-life 2022-10-19T15:19:46+00:00 0.5 https://www.galderma.com/news/galderma-launches-cetaphilr-line-sensitive-skin-and-new-daylongr-sun-protection-product 2022-10-19T15:44:01+00:00 0.5 https://www.galderma.com/news/how-galdermas-environmental-social-and-corporate-governance-approach-guides-its-roadmap 2022-10-19T15:42:27+00:00 0.5 https://www.galderma.com/news/alluziencer-first-ready-use-bont-neuromodulator-receives-positive-decision-use-europe 2022-10-19T15:23:04+00:00 0.5 https://www.galderma.com/news/sol-gel-technologies-and-galderma-announce-exclusive-licenses-commercialization-epsolayr-and-twyneo-in-the-united-states 2022-12-13T14:11:59+00:00 0.5 https://www.galderma.com/news/galderma-present-new-data-leading-aesthetics-portfolio-and-launch-restylaner-eyelighttm-amwc 2022-10-19T15:40:10+00:00 0.5 https://www.galderma.com/news/galderma-announces-exclusive-agreement-sofregen-develop-next-generation-biostimulator-fillers 2022-12-12T14:06:42+00:00 0.5 https://www.galderma.com/news/galderma-and-cetaphilr-announce-renewed-commitment-environmental-sustainability-and-social 2022-12-12T14:07:35+00:00 0.5 https://www.galderma.com/news/galderma-unveil-ground-breaking-data-across-its-leading-dermatology-portfolio-and-showcase 2022-10-19T15:36:57+00:00 0.5 https://www.galderma.com/news/galderma-presents-new-nemolizumab-data-eadv-reinforcing-rapid-onset-action-and-consistent 2022-10-19T15:36:41+00:00 0.5 https://www.galderma.com/news/restylaner-original-stabilized-hyaluronic-acid-filler-celebrates-25-years-unmatched 2022-10-19T15:17:49+00:00 0.5 https://www.galderma.com/news/maria-teresa-hilado-join-galdermas-advisory-committee 2022-10-19T15:18:10+00:00 0.5 https://www.galderma.com/news/galderma-announces-new-data-demonstrating-positive-anti-inflammatory-effect-and-mode-action 2022-10-19T15:18:57+00:00 0.5 https://www.galderma.com/news/galderma-acquire-award-winning-alastin-skincarer-enhancing-its-integrated-dermatology-platform 2022-12-12T14:12:12+00:00 0.5 https://www.galderma.com/news/addressing-gaps-acne-management-new-expert-recommendations-optimize-patient-care 2022-10-19T15:35:57+00:00 0.5 https://www.galderma.com/news/galderma-successfully-completes-acquisition-alastin-skincarer 2022-12-12T14:09:51+00:00 0.5 https://www.galderma.com/news/galderma-launches-alastin-skincarer-reform-repair-complex-trihex-technologyr-designed-assist 2022-12-12T14:10:31+00:00 0.5 https://www.galderma.com/news/karen-l-ling-joins-galdermas-advisory-committee-0 2022-10-19T15:24:50+00:00 0.5 https://www.galderma.com/news/taro-acquire-alchemee-galderma 2022-10-19T15:34:45+00:00 0.5 https://www.galderma.com/news/galderma-highlight-latest-science-and-innovation-across-its-product-portfolio-2022-aad-annual 2022-12-12T14:11:24+00:00 0.5 https://www.galderma.com/news/galderma-present-new-clinical-data-and-high-patient-satisfaction-across-their-portfolio-dermal 2022-10-19T15:17:24+00:00 0.5 https://www.galderma.com/news/galderma-launches-virtual-experience-rosacea-awareness-month-showcasing-how-condition-goes 2022-10-19T15:33:01+00:00 0.5 https://www.galderma.com/news/cetaphilr-debuts-global-sensitive-skin-awareness-initiative-0 2022-10-19T15:31:52+00:00 0.5 https://www.galderma.com/news/galderma-present-extensive-new-clinical-data-across-its-portfolio-neuromodulators-fillers-and 2024-02-19T11:14:27+00:00 0.5 https://www.galderma.com/news/galderma-present-new-findings-innovative-product-portfolio-2022-vcs-annual-symposium 2022-12-21T13:36:34+00:00 0.5 https://www.galderma.com/news/galderma-announces-positive-results-two-phase-iii-studies-novel-liquid-formulation 2022-12-21T13:36:05+00:00 0.5 https://www.galderma.com/news/galderma-announces-positive-data-phase-iii-trial-demonstrating-efficacy-and-safety-nemolizumab 2022-12-21T13:35:33+00:00 0.5 https://www.galderma.com/news/galderma-delivers-strong-h1-2022-results-and-continued-innovation-across-its-leading 2022-10-19T15:25:05+00:00 0.5 https://www.galderma.com/news/galderma-showcases-its-continued-commitment-innovation-dermatology-new-data-be-presented-0 2022-10-19T15:24:01+00:00 0.5 https://www.galderma.com/news/galderma-debuts-sensitive-skincare-faculty-global-expert-group-improve-understanding-and 2022-10-19T15:23:48+00:00 0.5 https://www.galderma.com/news/actinic-keratosis-prevention-campaign-encourages-everyone-face-facts 2022-10-24T12:16:58+00:00 0.5 https://www.galderma.com/news/galderma-study-paves-way-effective-new-acne-treatment-combination 2022-11-03T10:16:45+00:00 0.5 https://www.galderma.com/news/galderma-announces-intention-expand-manufacturing-and-innovation-footprint-asia-pacific 2022-10-19T15:23:24+00:00 0.5 https://www.galderma.com/news/galderma-expands-new-production-site-uppsala-sweden 2022-10-19T15:23:35+00:00 0.5 https://www.galderma.com/news/sales-data-confirm-galdermas-range-anti-acne-products-no1-choice-globally 2022-11-16T09:41:16+00:00 0.5 https://www.galderma.com/news/galderma-launches-novel-formulation-alastin-skincarer-luminate-brightening-serumr-developed 2023-07-17T11:50:04+00:00 0.5 https://www.galderma.com/news/new-data-galdermas-aesthetics-portfolio-be-presented-2022-asds-annual-meeting 2022-12-21T13:29:00+00:00 0.5 https://www.galderma.com/news/galderma-and-national-breast-cancer-foundation-announce-continued-partnership-launch-campaign 2024-02-19T11:12:28+00:00 0.5 https://www.galderma.com/news/cetaphilr-celebrates-75-years-sensitive-skincare-leadership 2022-12-21T13:30:38+00:00 0.5 https://www.galderma.com/news/galderma-and-childrens-skin-disease-foundation-celebrate-decade-long-partnership 2022-12-21T13:35:01+00:00 0.5 https://www.galderma.com/news/galderma-launches-epsolay-cream-medical-advance-treat-bumps-and-blemishes-rosacea 2022-12-21T13:37:19+00:00 0.5 https://www.galderma.com/news/sol-gel-technologies-and-galderma-announce-fda-approval-epsolay 2022-12-21T13:38:12+00:00 0.5 https://www.galderma.com/news/galderma-launches-twyneo-cream-first-ever-tretinoin-and-benzoyl-peroxide-combination-treat 2022-12-13T13:21:17+00:00 0.5 https://www.galderma.com/news/galderma-launches-breakthrough-innovation-alastin-skincarer-ha-immerse-serumr 2022-12-13T13:21:26+00:00 0.5 https://www.galderma.com/news/cetaphilr-champions-sensitive-skin-initiative-entire-month-science-backed-educational-content 2022-12-13T13:21:32+00:00 0.5 https://www.galderma.com/news/differin-joins-forces-expert-digital-voices-kickstart-acne-conversation-its-fifth-annual-1 2022-12-13T13:25:39+00:00 0.5 https://www.galderma.com/news/galderma-announces-relocation-us-headquarters-downtown-dallas 2023-01-26T10:41:02+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval-new-sculptra-label-offering-more-options-aesthetic-partners 2022-12-13T13:26:01+00:00 0.5 https://www.galderma.com/news/galderma-leads-oral-presentation-hyaluronic-acid-filler-safety-insights-asds-2021-annual 2022-12-13T13:26:11+00:00 0.5 https://www.galderma.com/news/restylaner-celebrates-25-years-natural-looking-results-its-signature-line-hyaluronic-acid 2022-12-13T13:26:20+00:00 0.5 https://www.galderma.com/news/cetaphilr-announces-major-evolution-brands-mission-advance-sensitive-skin-science 2022-12-13T13:26:29+00:00 0.5 https://www.galderma.com/news/sol-gel-technologies-announces-fda-approval-twyneor 2022-12-13T13:26:35+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval 2022-12-13T13:30:27+00:00 0.5 https://www.galderma.com/news/cetaphilr-champions-sun-protection-awareness-and-education-dermatologist-led-digital-campaign 2022-12-13T13:30:32+00:00 0.5 https://www.galderma.com/news/cetaphilr-launches-innovative-digital-campaign-connect-millions-consumers-experiencing-skin 2022-12-13T13:30:37+00:00 0.5 https://www.galderma.com/news/differinr-celebrates-fourth-annual-retinoid-education-week-offering-people-acne-chance-get 2022-12-13T13:30:43+00:00 0.5 https://www.galderma.com/news/galderma-announces-launch-face-change-program 2022-12-13T13:30:53+00:00 0.5 https://www.galderma.com/news/cetaphil-taps-rachel-brosnahan-creative-consultant-new-close-and-sensitive-digital-campaign 2022-12-13T13:31:00+00:00 0.5 https://www.galderma.com/news/cetaphilr-unveils-premium-product-line-new-hydrosensitivtm-complex-delivers-48-hour-hydration 2022-12-13T13:31:12+00:00 0.5 https://www.galderma.com/news/international-kissing-day-galderma-shares-first-its-kind-phase-iv-kissability-study-results 2022-12-13T13:31:17+00:00 0.5 https://www.galderma.com/news/galderma-announces-acceleration-its-growth-and-expansion-plans-support-aesthetic-providers 2022-12-13T13:31:22+00:00 0.5 https://www.galderma.com/news/differinr-launches-clear90tm-app-support-people-acne-their-clear-skin-journey-part-third 2022-12-13T13:31:27+00:00 0.5 https://www.galderma.com/news/fort-worths-galderma-maker-cetaphil-presents-5th-annual-wonder-run-5k-and-kids-1k-benefit 2022-12-13T13:31:32+00:00 0.5 https://www.galderma.com/news/cetaphilr-announces-partnership-award-winning-actress-rachel-brosnahan 2022-12-13T13:31:38+00:00 0.5 https://www.galderma.com/news/decade-dysportr-galderma-celebrates-10-years-fda-approval-dysport-us 2022-12-13T13:36:45+00:00 0.5 https://www.galderma.com/news/galderma-announces-us-collaboration-nespresso 2022-12-13T13:36:49+00:00 0.5 https://www.galderma.com/news/galderma-announces-new-collaborations-top-aesthetic-professional-skincare-brands 2022-12-13T13:36:58+00:00 0.5 https://www.galderma.com/news/galderma-announces-fda-approval-restylaner-lyft-midface-injection-cannula 2022-12-13T13:37:05+00:00 0.5 https://www.galderma.com/news/fort-worths-galderma-maker-cetaphil-presents-4th-annual-wonder-run-5k-and-1k-kids-waddle 2022-12-13T13:37:11+00:00 0.5 https://www.galderma.com/news/galderma-partners-national-breast-cancer-foundation-4th-annual-pink-day-event-increase-breast 2022-12-13T13:37:16+00:00 0.5 https://www.galderma.com/news/galderma-announces-aspire-rewards-program-reaches-one-million-members 2022-12-13T13:37:21+00:00 0.5 https://www.galderma.com/news/galderma-initiates-six-new-studies-increasing-commitment-to-aesthetic-research 2022-12-13T13:37:26+00:00 0.5 https://www.galderma.com/news/world-renowned-celebrity-and-fashion-manicurist-deborah-lippmann-joins-forces-galderma-face 2022-12-13T13:37:30+00:00 0.5 https://www.galderma.com/news/nestle-skin-health-announces-fda-approval-restylane-lyft-hands-first-and-only-hyaluronic-acid 2022-12-13T13:37:35+00:00 0.5 https://www.galderma.com/news/galderma-announces-results-alamo-real-world-phase-4-study-demonstrating-efficacy-and-safety 2022-12-13T13:37:40+00:00 0.5 https://www.galderma.com/news/new-phase-4-oscar-trial-data-showed-epiduo-forte-adapalene-and-benzoyl-peroxide-gel 2022-12-13T13:37:45+00:00 0.5 https://www.galderma.com/news/leading-acne-brand-launches-first-ever-retinoid-education-week 2022-12-13T13:37:49+00:00 0.5 https://www.galderma.com/news/differin-expands-portfolio-addition-two-new-facial-skincare-products 2022-12-13T13:37:55+00:00 0.5 https://www.galderma.com/news/galderma-pure-play-dermatology-category-leader-and-maker-cetaphil-celebrates-grand-opening-us 2023-01-26T10:42:23+00:00 0.5 https://www.galderma.com/news/full-spectrum-dermatology-diverse-and-inclusive-atlas-launches-new-free-online-image-gallery 2023-01-13T16:17:32+00:00 0.5 https://www.galderma.com/news/imcas-2023-galderma-share-latest-data-demonstrating-high-aesthetic-improvement-and-patient 2024-02-19T11:09:37+00:00 0.5 https://www.galderma.com/news/galderma-expands-footprint-new-global-capability-center-barcelona-support-global-growth-1 2023-01-23T15:26:54+00:00 0.5 https://www.galderma.com/news/galderma-announces-launch-face-galdermatm-game-changing-augmented-reality-solution-helping 2024-02-19T11:11:19+00:00 0.5 https://www.galderma.com/news/galderma-launches-cutting-edge-formulation-alastin-skincarer-resurface-skin-polish-developed 2023-02-06T20:39:18+00:00 0.5 https://www.galderma.com/news/cetaphil-raises-awareness-connection-between-clothing-and-sensitive-skin 2023-02-16T18:58:39+00:00 0.5 https://www.galderma.com/news/cetaphilr-unveils-digital-ai-skin-analysis-tool-empower-and-educate-users-sensitive-skin-0 2023-03-02T15:00:08+00:00 0.5 https://www.galderma.com/news/galderma-delivers-strong-fy-2022-growth-driven-innovation-and-commercial-performance 2023-03-13T05:59:40+00:00 0.5 https://www.galderma.com/news/cetaphil-celebrates-global-initiative-highlighting-sensitive-skin-month-skin-science-education 2023-03-15T15:05:05+00:00 0.5 https://www.galderma.com/news/aad-2023-late-breaking-phase-iii-results-demonstrate-nemolizumabs-significant-impact-prurigo-1 2023-03-18T15:00:02+00:00 0.5 https://www.galderma.com/news/aad-2023-extensive-updates-galdermas-broad-and-innovative-portfolio-through-posters-and 2023-03-17T14:55:28+00:00 0.5 https://www.galderma.com/news/galderma-launches-face-galdermatm-cutting-edge-aesthetic-visualization-tool-simulates 2023-03-22T15:38:05+00:00 0.5 https://www.galderma.com/news/amwc-2023-data-galdermas-broad-aesthetic-portfolio 2023-03-27T19:41:42+00:00 0.5 https://www.galderma.com/news/amwc-2023-data-sculptrar-cheek-wrinkle-and-alluziencer-star-studies-reinforce-strength 2023-03-30T06:40:53+00:00 0.5 https://www.galderma.com/news/augmented-reality-patient-experience-trumps-misconceptions-around-injectables 2023-04-19T07:33:05+00:00 0.5 https://www.galderma.com/news/galderma-receives-fda-approval-sculptrar-cheek-wrinkles-0 2023-04-26T12:33:10+00:00 0.5 https://www.galderma.com/news/acne-awareness-month-2023-driving-education-acne-answered 2023-05-30T15:01:46+00:00 0.5 https://www.galderma.com/GaldermaFDAapprovalforRestylaneEyelight 2023-06-05T13:23:09+00:00 0.5 https://www.galderma.com/news/wcd-2023-galderma-present-extensive-data-demonstrating-enduring-commitment-delivering 2023-06-29T08:13:10+00:00 0.5 https://www.galderma.com/news/galderma-wcd-2023-late-breaking-phase-iii-results-nemolizumab-monotherapy-prurigo-nodularis 2023-07-13T07:21:05+00:00 0.5 https://www.galderma.com/news/galderma-raises-approximately-usd-1-billion-newly-issued-shares-private-placement-round 2023-07-28T12:08:02+00:00 0.5 https://www.galderma.com/news/wcd-2023-galdermas-scientific-presentations 2023-06-28T06:54:47+00:00 0.5 https://www.galderma.com/news/galderma-achieves-record-2-b-usd-net-sales-six-month-period-h1-2023-it-continues-demonstrate 2023-11-20T15:07:14+00:00 0.5 https://www.galderma.com/news/galderma-reiterates-its-commitment-commercialize-and-continue-developing-broadest-injectable 2023-07-29T15:35:02+00:00 0.5 https://www.galderma.com/news/powered-peptides-galderma-introduces-cetaphil-healthy-renew-retinol-alternative-skincare-range 2025-11-19T11:30:36+00:00 0.5 https://www.galderma.com/news/galderma-launches-advanced-new-serum-alastin-skincarer-c-radical-defense-antioxidant-serum 2025-11-19T11:30:36+00:00 0.5 https://www.galderma.com/news/galdermas-world-eczema-week-driving-change-community 2023-09-14T11:25:40+00:00 0.5 https://www.galderma.com/news/alastin-skincare-galderma-announces-launch-uk-and-direct-distribution-and-expansion-canada 2023-10-02T15:54:42+00:00 0.5 https://www.galderma.com/news/eadv-2023-galderma-present-new-data-showcasing-its-continued-leadership-dermatology 2023-10-04T04:57:13+00:00 0.5 https://www.galderma.com/news/galderma-announces-progress-relabotulinumtoxina-regulatory-submissions 2023-10-02T20:25:22+00:00 0.5 https://www.galderma.com/news/eadv-2023-galdermas-scientific-presentations 2023-10-04T04:38:36+00:00 0.5 https://www.galderma.com/news/product-any-type-skin-celebrating-cetaphils-range-and-reliability 2023-10-03T14:17:33+00:00 0.5 https://www.galderma.com/news/galderma-eadv-2023-phase-iii-trials-demonstrate-nemolizumabs-efficacy-and-rapid-onset-action 2023-10-11T16:45:47+00:00 0.5 https://www.galderma.com/news/galderma-unveils-bold-ambition-neuromodulation-liquid-live-event-1 2023-10-13T10:10:47+00:00 0.5 https://www.galderma.com/news/providing-optimal-care-optimal-results-cetaphil 2023-10-23T08:45:49+00:00 0.5 https://www.galderma.com/news/galderma-phase-iii-data-published-new-england-journal-medicine-full-olympia-2-trial-results 2024-05-01T13:35:42+00:00 0.5 https://www.galderma.com/news/galderma-reports-record-net-sales-over-3-b-usd-first-nine-months-2023-strong-growth-momentum 2023-11-21T05:52:45+00:00 0.5 https://www.galderma.com/news/our-culture 2025-03-27T14:31:14+00:00 0.5 https://www.galderma.com/news/results-galdermas-phase-iiib-trials-demonstrate-rapid-and-long-lasting-effect-0 2023-11-30T05:54:17+00:00 0.5 https://www.galderma.com/news/centering-patient-needs-dr-shridharanis-shared-values-galderma 2023-12-07T12:46:20+00:00 0.5 https://www.galderma.com/news/common-purpose 2024-01-10T17:29:19+00:00 0.5 https://www.galderma.com/news/toxins-2024-galdermas-phase-iii-relabotulinumtoxina-results-demonstrate-positive-efficacy-and 2024-02-19T11:08:04+00:00 0.5 https://www.galderma.com/news/toxins-2024-galdermas-poster-presentations 2024-01-17T05:47:23+00:00 0.5 https://www.galderma.com/news/galderma-announces-regulatory-approval-restylaner-shaypetm-new-hyaluronic-acid-injectable 2024-01-22T07:37:04+00:00 0.5 https://www.galderma.com/news/collaborative-growth 2024-01-22T14:09:31+00:00 0.5 https://www.galderma.com/news/imcas-2024-galdermas-scientific-presentations 2024-01-25T05:13:01+00:00 0.5 https://www.galderma.com/news/imcas-2024-galderma-present-latest-updates-its-unparalleled-aesthetics-portfolio-reinforcing 2024-01-25T05:54:03+00:00 0.5 https://www.galderma.com/news/remarkable-journey-restylane-lab-patient 2024-01-29T09:56:19+00:00 0.5 https://www.galderma.com/news/galderma-celebrates-25-years-excellence-biostimulation-sculptrar-2024-imcas 2024-02-02T05:48:12+00:00 0.5 https://www.galderma.com/news/galderma-launches-next-ground-breaking-trend-report-unveils-future-aesthetics 2024-02-07T08:01:20+00:00 0.5 https://www.galderma.com/news/galderma-takes-face-cetaphilr-runway-new-york-city-fashion-week 2024-02-08T15:56:41+00:00 0.5 https://www.galderma.com/news/making-impact 2024-02-12T14:08:43+00:00 0.5 https://www.galderma.com/news/galderma-announces-regulatory-filing-acceptance-nemolizumab-prurigo-nodularis-and-atopic 2024-02-14T09:46:51+00:00 0.5 https://www.galderma.com/news/aad-2024-scientific-presentations-supported-galderma 2024-02-28T05:27:52+00:00 0.5 https://www.galderma.com/news/galderma-showcase-latest-updates-its-broad-innovative-and-leading-dermatology-portfolio-2024 2024-02-28T05:46:21+00:00 0.5 https://www.galderma.com/news/galderma-announces-record-2023-net-sales-over-4-b-usd-and-significant-core-ebitda-margin 2024-02-29T05:42:57+00:00 0.5 https://www.galderma.com/news/galderma-aad-2024-new-data-demonstrate-long-term-efficacy-nemolizumab-prurigo-nodularis-and 2024-03-10T19:54:56+00:00 0.5 https://www.galderma.com/news/galderma-announces-intention-float-six-swiss-exchange 2024-03-06T05:52:51+00:00 0.5 https://www.galderma.com/news/were-inspired-our-people 2024-03-13T17:04:19+00:00 0.5 https://www.galderma.com/news/galderma-launches-ipo-six-swiss-exchange-and-sets-price-range-0 2024-03-13T06:28:29+00:00 0.5 https://www.galderma.com/news/dr-flor-mayoral-story-creativity-passion-and-dermatological-innovation-galderma 2024-03-13T16:59:40+00:00 0.5 https://www.galderma.com/news/amwc-2024-scientific-presentations-supported-galderma 2024-03-19T10:09:32+00:00 0.5 https://www.galderma.com/news/amwc-2024-galderma-share-new-data-its-leading-injectable-aesthetic-portfolio 2024-03-19T10:46:03+00:00 0.5 https://www.galderma.com/news/galderma-prices-ipo-chf-53-share-and-will-start-trading-six-swiss-exchange-tomorrow 2024-03-21T06:30:11+00:00 0.5 https://www.galderma.com/news/galderma-announces-full-exercise-over-allotment-option 2024-03-26T19:29:32+00:00 0.5 https://www.galderma.com/news/celebrating-galdermas-listing-six-swiss-exchange 2024-03-27T16:27:25+00:00 0.5 https://www.galderma.com/news/organization-built-uniqueness 2024-04-09T12:53:55+00:00 0.5 https://www.galderma.com/news/galderma-delivers-strong-start-year-record-net-sales-over-1-billion-usd-first-quarter-and-124 2024-07-25T04:50:01+00:00 0.5 https://www.galderma.com/news/galderma-receives-filing-acceptances-nemolizumab-prurigo-nodularis-and-atopic-dermatitis-four 2024-05-22T15:36:52+00:00 0.5 https://www.galderma.com/news/galderma-launches-restylaner-volymetm-china-one-worlds-fastest-growing-aesthetics-markets 2024-05-23T04:48:47+00:00 0.5 https://www.galderma.com/news/acne-awareness-month-2024-understanding-acne-scarring 2024-06-03T14:50:50+00:00 0.5 https://www.galderma.com/news/galderma-granted-key-manufacturing-license-updates-new-biologics-capabilities-its-center 2024-06-19T04:45:13+00:00 0.5 https://www.galderma.com/news/galderma-introduces-high-potency-cetaphil-serums-designed-sensitive-skin 2024-07-09T05:03:49+00:00 0.5 https://www.galderma.com/news/shaping-future-gerry-muhle-technologies-driving-dermatology 2024-07-01T15:39:04+00:00 0.5 https://www.galderma.com/news/galderma-delivers-record-net-sales-22-billion-usd-and-108-year-year-growth-constant-currency 2024-07-25T04:52:20+00:00 0.5 https://www.galderma.com/news/phase-iii-arcadia-1-and-2-trial-primary-results-published-lancet-galdermas-nemolizumab 2024-07-25T04:28:12+00:00 0.5 https://www.galderma.com/news/galdermas-relfydesstm-relabotulinumtoxina-receives-positive-decision-use-europe 2024-07-30T04:49:18+00:00 0.5 https://www.galderma.com/news/galderma-pursue-new-scientific-partnership-loreal-further-advance-its-category-leadership 2024-08-05T12:27:11+00:00 0.5 https://www.galderma.com/news/galderma-receives-us-fda-approval-nemluvior-nemolizumab-adult-patients-living-prurigo 2024-08-13T11:24:41+00:00 0.5 https://www.galderma.com/news/galderma-successfully-issued-inaugural-chf-500-million-bond 2024-08-29T04:49:36+00:00 0.5 https://www.galderma.com/news/galderma-launches-cetaphil-gentle-exfoliating-line-gen-z-it-girl-katie-fang 2025-11-19T11:30:36+00:00 0.5 https://www.galderma.com/news/identifying-unmet-patient-needs-world-atopic-eczema-day-0 2024-09-13T07:53:04+00:00 0.5 https://www.galderma.com/news/galderma-reaffirms-its-leadership-dermatology-extensive-presence-eadv-2024 2024-09-17T04:46:12+00:00 0.5 https://www.galderma.com/news/eadv-2024-scientific-presentations-supported-galderma 2024-09-17T11:54:09+00:00 0.5 https://www.galderma.com/news/eadv-2024-late-breaking-news-sessions-new-galderma-data-demonstrating-nemolizumabs-long-term 2024-09-25T04:45:37+00:00 0.5 https://www.galderma.com/news/asds-2024-galderma-presents-data-relabotulinumtoxina-and-sculptrar 2024-10-18T10:31:20+00:00 0.5 https://www.galderma.com/news/asds-2024-new-phase-iii-ready-4-data-demonstrate-long-term-safety-and-efficacy-galdermas 2024-10-21T04:58:23+00:00 0.5 https://www.galderma.com/news/galderma-delivers-record-net-sales-3259-b-usd-first-nine-months-2024-demonstrates-0 2024-10-24T06:00:22+00:00 0.5 https://www.galderma.com/news/galderma-brings-together-over-650-healthcare-professionals-asia-pacific-elevate-knowledge 2024-10-25T04:49:15+00:00 0.5 https://www.galderma.com/news/celebrating-25-years-sculptrar-new-data-and-recent-approval-china-cements-galdermas-leadership 2024-11-04T05:46:42+00:00 0.5 https://www.galderma.com/news/galdermas-phase-iii-olympia-1-data-published-jama-dermatology-demonstrate-nemolizumab-improves 2024-11-28T05:48:16+00:00 0.5 https://www.galderma.com/news/chmp-recommends-approval-galdermas-nemolizumab-moderate-severe-atopic-dermatitis-and-prurigo 2024-12-14T05:38:30+00:00 0.5 https://www.galderma.com/news/galderma-receives-us-fda-approval-nemluvior-nemolizumab-patients-moderate-severe-atopic 2024-12-14T07:43:28+00:00 0.5 https://www.galderma.com/news/beyond-trends-equipping-aesthetics-community-whats-next 2024-12-19T10:00:24+00:00 0.5 https://www.galderma.com/news/galderma-premieres-positive-interim-results-demonstrating-efficacy-its-injectable-aesthetics 2025-01-14T05:42:11+00:00 0.5 https://www.galderma.com/news/imcas-2025-galdermas-scientific-presentations 2025-01-23T05:23:36+00:00 0.5 https://www.galderma.com/news/imcas-2025-galdermas-broad-presence-and-new-data-recently-launched-products-restylaner 2025-01-23T05:40:52+00:00 0.5 https://www.galderma.com/news/galderma-demonstrates-injectable-aesthetics-leadership-medication-driven-weight-loss-new 2025-01-30T06:01:36+00:00 0.5 https://www.galderma.com/news/imcas-2025-new-galderma-phase-iiib-data-reinforce-rapid-onset-and-long-lasting-aesthetic 2025-01-31T05:41:56+00:00 0.5 https://www.galderma.com/news/galdermas-nemluvior-nemolizumab-approved-european-union-moderate-severe-atopic-dermatitis-and 2025-02-14T05:46:59+00:00 0.5 https://www.galderma.com/news/galdermas-nemluvior-nemolizumab-granted-marketing-authorization-united-kingdom-and-0 2025-02-18T05:48:46+00:00 0.5 https://www.galderma.com/news/aad-2025-galdermas-scientific-presentations 2025-03-03T05:48:25+00:00 0.5 https://www.galderma.com/news/aad-2025-galderma-present-extensive-updates-across-its-dermatology-portfolio-demonstrating-its 2025-03-03T05:47:39+00:00 0.5 https://www.galderma.com/news/galderma.com/news/2024-annual-results 2025-03-06T05:59:05+00:00 0.5 https://www.galderma.com/news/galderma-bonds 2025-03-14T05:55:46+00:00 0.5 https://www.galderma.com/news/galdermas-differin-helping-destigmatize-acne-care-first-category-roblox-experience 2025-03-17T11:59:51+00:00 0.5 https://www.galderma.com/news/amwc-2025-galdermas-scientific-presentations 2025-03-20T05:38:06+00:00 0.5 https://www.galderma.com/news/amwc-2025-galderma-pushes-innovation-frontier 2025-03-20T05:57:08+00:00 0.5 https://www.galderma.com/news/2024-annual-report-annual-general-meeting 2025-03-21T05:59:38+00:00 0.5 https://www.galderma.com/news/galderma-launches-sculptrar-china 2025-04-15T04:56:16+00:00 0.5 https://www.galderma.com/news/alastin-restorative-skin-complex-next-generation-trihex-technology 2025-04-17T04:56:59+00:00 0.5 https://www.galderma.com/news/galderma-launches-scratch-resistance-campaign-validate-physical-and-emotional-burdens-atopic 2025-04-22T09:57:46+00:00 0.5 https://www.galderma.com/news/galderma-shareholders-approve-all-annual-general-meeting-proposals 2025-04-23T16:01:03+00:00 0.5 https://www.galderma.com/news/galderma-Q12025-performance 2025-04-24T04:55:22+00:00 0.5 https://www.galderma.com/news/share-buy-back-intent 2025-05-27T15:45:06+00:00 0.5 https://www.galderma.com/news/shares-buys-back-exercice 2025-05-28T05:08:45+00:00 0.5 https://www.galderma.com/news/revolutionizing-atopic-dermatitis-2025-conference-galdermas-scientific-presentations 2025-06-06T04:30:29+00:00 0.5 https://www.galderma.com/news/rad-2025-nemluvio 2025-06-06T04:50:53+00:00 0.5 https://www.galderma.com/news/international-congress-dermatology-2025-galdermas-scientific-presentations 2025-06-10T13:30:01+00:00 0.5 https://www.galderma.com/news/icd-2025-new-data-nemluvio-prurigo-nodularis 2025-06-18T04:59:29+00:00 0.5 https://www.galderma.com/news/galderma-establishes-new-us-headquarters-miami-and-strengthens-regional-leadership 2025-06-17T16:58:42+00:00 0.5 https://www.galderma.com/news/acne-awareness-month-lets-talk-about-acne 2025-06-23T08:48:23+00:00 0.5 https://www.galderma.com/news/galderma-initiates-two-new-clinical-trials 2025-07-22T11:56:37+00:00 0.5 https://www.galderma.com/news/breaking-through-surface-sensitive-skin 2025-06-25T11:41:28+00:00 0.5 https://www.galderma.com/news/galderma-announces-departure-its-chief-financial-officer 2025-07-01T05:00:58+00:00 0.5 https://www.galderma.com/news/scratching-surface-shedding-light-misunderstood-skin-disease 2025-07-09T11:51:08+00:00 0.5 https://www.galderma.com/news/galderma-unveils-final-nine-month-data-medication-driven-weight-loss 2025-07-17T04:59:15+00:00 0.5 https://www.galderma.com/news/more-skin-deep-daily-reality-atopic-dermatitis 2025-07-18T12:44:36+00:00 0.5 https://www.galderma.com/news/galderma-H12025-performance 2025-07-31T15:48:04+00:00 0.5 https://www.galderma.com/news/10-years-gain-inspiring-aesthetic-education-and-excellence 2025-07-31T14:20:53+00:00 0.5 https://www.galderma.com/news/galderma-introduces-cetaphil-nourishing-oil-foam-cleanser-breakthrough-hydrating-cleansing 2025-08-25T13:01:44+00:00 0.5 https://www.galderma.com/news/advancing-future-dermatology-robust-it 2025-08-28T07:50:36+00:00 0.5 https://www.galderma.com/news/eadv-2025-scientific-presentations-supported-galderma 2025-09-03T14:32:47+00:00 0.5 https://www.galderma.com/news/galderma-launches-alastin-china 2025-09-10T10:04:00+00:00 0.5 https://www.galderma.com/news/eadv-2025-galderma-reinforces-leadership-dermatology-latest-advances-sensitive-skin-and-itch 2025-09-11T04:57:11+00:00 0.5 https://www.galderma.com/news/galderma-launches-cetaphils-skin-activator 2025-09-18T04:58:15+00:00 0.5 https://www.galderma.com/news/galdermas-study-modern-living-sensitive-skin 2025-09-17T14:52:11+00:00 0.5 https://www.galderma.com/news/AMWC-Dubai-2025-Galderma-Scientific-Presentations 2025-09-24T04:42:12+00:00 0.5 https://www.galderma.com/news/amwc-dubai-galderma-demonstrates-injectable-aesthetics-leadership 2025-09-25T08:03:31+00:00 0.5 https://www.galderma.com/news/galderma-Q32025-performance 2025-10-23T05:01:07+00:00 0.5 https://www.galderma.com/news/two-patients-one-condition-overlooked-impact-atopic-dermatitis-families 2025-10-29T12:12:35+00:00 0.5 https://www.galderma.com/news/galderma-receives-us-fda-approval-restylane-lyft 2025-11-05T06:00:37+00:00 0.5 https://www.galderma.com/news/asds-2025-galdermas-scientific-presentations 2025-11-10T15:38:01+00:00 0.5 https://www.galderma.com/news/asds-2025 2025-11-17T06:00:57+00:00 0.5 https://www.galderma.com/news/galderma-completes-successful-placement-chf-175-million-bond 2025-11-14T06:00:37+00:00 0.5 https://www.galderma.com/news/galderma-secures-bbb-credit-rating-positive-outlook-sp-global-ratings 2025-12-04T06:00:31+00:00 0.5 https://www.galderma.com/news/sculptra-mdr-certification-body 2025-12-08T05:32:03+00:00 0.5 https://www.galderma.com/news/galderma-welcomes-increased-equity-investment-loreal 2025-12-08T06:05:46+00:00 0.5 https://www.galderma.com/news/first-patient-enrollment-nemolizumab-chronic-pruritus 2025-12-11T08:36:44+00:00 0.5 https://www.galderma.com/news/gain-ascent-summit-our-training-program-emerging-injectors-marks-end-gains-first-decade 2025-12-11T14:21:12+00:00 0.5 https://www.galderma.com/news/prurigo-nodularis-long-road-diagnosis 2025-12-15T21:40:30+00:00 0.5 https://www.galderma.com/news/nemluvio-rapidly-relieve-itch-and-improve-sleep 2025-12-17T11:23:21+00:00 0.5 https://www.galderma.com/news/toxins-2026-galdermas-scientific-presentations 2026-01-13T10:41:27+00:00 0.5 https://www.galderma.com/news/toxins-2026-clinical-updates-galdermas-leading-neuromodulator-portfolio 2026-01-14T06:01:16+00:00 0.5 https://www.galderma.com/news/imcas-2026-galderma-showcases-latest-scientific-advances 2026-01-22T06:00:17+00:00 0.5 https://www.galderma.com/news/galderma-provides-update-arbitration-case-regarding-neuromodulator-research-and-development 2026-01-21T16:35:29+00:00 0.5 https://www.galderma.com/news/imcas-2026-galdermas-scientific-presentations 2026-01-21T14:18:53+00:00 0.5 https://www.galderma.com/news/galderma-unveils-wake-restylane 2026-01-29T06:00:34+00:00 0.5 https://www.galderma.com/news/galderma-tackles-menopause-related-skin-changes 2026-01-30T06:00:53+00:00 0.5 https://www.galderma.com/news/galderma-us-fda-acceptance-relabotulinumtoxina-application 2026-02-02T06:00:39+00:00 0.5 https://www.galderma.com/news/galderma-expands-restylane-portfolio-japan 2026-02-11T06:00:57+00:00 0.5 https://www.galderma.com/news/we-are-all-sculptra 2026-02-12T06:22:51+00:00 0.5 https://www.galderma.com/news/galderma-announces-appointment-new-chief-financial-officer 2026-02-16T06:00:42+00:00 0.5 https://www.galderma.com/news/expanding-our-global-footprint-new-krakow-global-capability-center 2026-02-20T11:09:12+00:00 0.5 https://www.galderma.com/news/galderma-announces-triple-approval-new-state-art-restylane-syringe 2026-02-25T06:03:27+00:00 0.5 https://www.galderma.com/news/galdermas-nemluvio-demonstrates-long-term-disease-control-prurigo-nodularis 2026-02-27T06:00:37+00:00 0.5 https://www.galderma.com/news/galderma-delivers-record-2025-results 2026-03-05T06:50:46+00:00 0.5 https://www.galderma.com/news/galderma-introduces-cetaphil-ampm-antioxidant-serums 2026-03-09T06:00:26+00:00 0.5 https://www.galderma.com/news/pioneering-study-deepens-our-understanding-sensitive-skin 2026-03-11T08:39:16+00:00 0.5 https://www.galderma.com/news/galderma-completes-successful-placement-eur-500-million-eurobond 2026-03-11T05:56:33+00:00 0.5 https://www.galderma.com/news/galderma-buys-back-shares-worth-chf-232-million-context-accelerated-bookbuild-offering 2026-03-11T06:01:11+00:00 0.5 https://www.galderma.com/news/amwc-monaco-2026-galderma-scientific-presentations 2026-03-17T08:43:44+00:00 0.5 https://www.galderma.com/news/amwc-2026-galderma 2026-03-17T08:44:25+00:00 0.5 https://www.galderma.com/news/aad-2026-galderma-scientific-presentations 2026-03-24T08:11:17+00:00 0.5 https://www.galderma.com/news/galderma-publishes-invitation-and-agenda-its-2026-annual-general-meeting 2026-03-20T05:55:13+00:00 0.5 https://www.galderma.com/news/galderma-receives-us-fda-approval-restylaner-contourtm-correction-temple-hollowing 2026-03-23T06:00:42+00:00 0.5 https://www.galderma.com/news/aad-2026-galderma 2026-03-24T08:12:02+00:00 0.5 https://www.galderma.com/news/aad-2026-late-breaking-data-atopic-dermatitis 2026-03-28T15:00:39+00:00 0.5 https://www.galderma.com/fr-fr/france 2026-02-17T09:04:51+00:00 0.5 https://www.galderma.com/es-es/espana 2025-06-24T06:33:27+00:00 0.5 https://www.galderma.com/pt-pt/portugal 2025-06-26T09:42:11+00:00 0.5 https://www.galderma.com/jp-jp/japan 2026-03-26T09:54:18+00:00 0.5 https://www.galderma.com/de-de/germany 2025-12-10T10:23:35+00:00 0.5 https://www.galderma.com/ru-ru/russia 2024-11-13T11:50:35+00:00 0.5 https://www.galderma.com/ru-ru/%D0%9C%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%B8%D0%B5-%D1%80%D0%B5%D1%88%D0%B5%D0%BD%D0%B8%D1%8F 2025-01-14T12:12:11+00:00 0.5 https://www.galderma.com/de-de/impressum 2025-10-16T12:29:11+00:00 0.5 https://www.galderma.com/de-de/datenschutz-at 2024-04-16T12:22:36+00:00 0.5 https://www.galderma.com/de-de/datenschutzerklaerung 2025-05-07T12:04:36+00:00 0.5 https://www.galderma.com/de-de/agb-avb 2025-05-16T16:57:23+00:00 0.5 https://www.galderma.com/de-de/qualitaet-arzneimittelsicherheit 2024-03-13T16:09:22+00:00 0.5 https://www.galderma.com/de-de/arzneimittelsicherheit-at 2024-03-26T14:03:42+00:00 0.5 https://www.galderma.com/us-en/united-states 2026-01-28T15:04:10+00:00 0.5 https://www.galderma.com/sa-ar/kingdom-saudi-arabia 2025-09-09T14:36:18+00:00 0.5 https://www.galderma.com/sa-en/kingdom-saudi-arabia 2025-09-09T14:36:18+00:00 0.5 https://www.galderma.com/sa-ar/kingdom-saudi-arabia/terms-of-use 2025-05-13T11:43:15+00:00 0.5 https://www.galderma.com/sa-en/kingdom-saudi-arabia/terms-of-use 2025-05-13T11:43:15+00:00 0.5 https://www.galderma.com/sa-ar/kingdom-saudi-arabia/cookie-policy 2025-05-13T11:46:59+00:00 0.5 https://www.galderma.com/sa-en/kingdom-saudi-arabia/cookie-policy 2025-05-13T11:46:59+00:00 0.5 https://www.galderma.com/sa-ar/kingdom-saudi-arabia/privacy-policy 2025-05-13T11:49:27+00:00 0.5 https://www.galderma.com/sa-en/kingdom-saudi-arabia/privacy-policy 2025-05-13T11:49:27+00:00 0.5 https://www.galderma.com/br-pt/brasil 2025-09-19T17:24:41+00:00 0.5 https://www.galderma.com/se-se/sweden 2025-10-15T10:33:08+00:00 0.5 https://www.galderma.com/se-se/regional-news-archieve 2025-10-09T12:33:07+00:00 0.5 https://www.galderma.com/es-es/lanzamiento-cetaphil-daily-advance 2023-10-11T09:12:53+00:00 0.5 https://www.galderma.com/es-es/nuevas-formulas-cetaphil 2023-10-11T08:57:54+00:00 0.5 https://www.galderma.com/es-es/lineas-de-expresion 2023-07-05T15:14:32+00:00 0.5 https://www.galderma.com/es-es/preguntas-frecuentes-rellenos 2023-07-05T15:16:11+00:00 0.5 https://www.galderma.com/es-es/tratamientos-skinboosters 2023-07-05T15:15:52+00:00 0.5 https://www.galderma.com/pt-pt/novas-formulas-cetaphil 2023-07-06T10:16:57+00:00 0.5 https://www.galderma.com/es-es/galderma-es-great-place-to-work 2023-07-06T14:27:35+00:00 0.5 https://www.galderma.com/es-es/cetaphil-lanza-nueva-crema-espuma-limpiadora 2023-10-11T08:51:17+00:00 0.5 https://www.galderma.com/es-es/calidad-de-la-piel 2023-10-16T10:19:49+00:00 0.5 https://www.galderma.com/pt-pt/qualidade-da-pele 2023-10-18T10:19:41+00:00 0.5 https://www.galderma.com/pt-pt/creme-espuma-de-limpeza-cetaphil 2023-10-18T14:53:02+00:00 0.5 https://www.galderma.com/es-es/tu-belleza-cuenta-explorando-la-medicina-estetica-integral 2023-12-04T11:10:17+00:00 0.5 https://www.galderma.com/es-es/tu-belleza-cuenta-piel-salud-mental-medicina-estetica 2023-12-04T11:03:05+00:00 0.5 https://www.galderma.com/jp-jp/news/Restylane-conference-JSAD2023 2023-12-19T06:50:37+00:00 0.5 https://www.galderma.com/jp-jp/news/cetaphil-conference-JDA2023 2023-11-14T10:12:00+00:00 0.5 https://www.galderma.com/jp-jp/news/cetaphil-PRO-renewal 2023-11-14T10:12:52+00:00 0.5 https://www.galderma.com/jp-jp/news/new-tokyo-office 2023-11-14T10:12:17+00:00 0.5 https://www.galderma.com/jp-jp/news/cetaphil-rakuten 2023-11-14T10:12:33+00:00 0.5 https://www.galderma.com/es-es/tu-belleza-cuenta-el-poder-de-la-hidratacion 2023-11-20T16:24:38+00:00 0.5 https://www.galderma.com/es-es/cetaphil-ganadora-premios-correo-farmaceutico 2024-02-09T09:24:18+00:00 0.5 https://www.galderma.com/es-es/tu-belleza-cuenta-potencia-tu-belleza-en-navidad 2023-12-01T08:58:29+00:00 0.5 https://www.galderma.com/es-es/face-to-face-priyanka 2024-01-16T14:09:31+00:00 0.5 https://www.galderma.com/es-es/webinar-dermatitis-atopica 2024-01-16T14:31:05+00:00 0.5 https://www.galderma.com/pt-pt/linhas-expressao 2024-01-16T14:42:09+00:00 0.5 https://www.galderma.com/es-es/Cetaphil-en-la-Semana-Moda-New-York 2024-03-06T14:47:41+00:00 0.5 https://www.galderma.com/pt-pt/Cetaphil-Semana-da-Moda-Noya-Iorque 2024-02-09T10:20:55+00:00 0.5 https://www.galderma.com/jp-jp/node/3704 2024-03-08T07:16:13+00:00 0.5 https://www.galderma.com/es-es/Cetaphil-Pilar-Rubio 2024-05-20T12:43:18+00:00 0.5 https://www.galderma.com/es-es/Comounamandibulabiendefinidatehacelucirmasjoven 2024-06-03T15:40:54+00:00 0.5 https://www.galderma.com/es-es/encaralarosacea 2024-06-03T15:29:19+00:00 0.5 https://www.galderma.com/es-es/Comoequilibrartuaspecto 2024-06-03T15:24:09+00:00 0.5 https://www.galderma.com/pt-pt/equilibrar-apar%C3%AAncia 2024-06-05T15:20:30+00:00 0.5 https://www.galderma.com/jp-jp/node/3741 2024-06-17T08:13:54+00:00 0.5 https://www.galderma.com/jp-jp/node/3748 2024-07-16T04:52:57+00:00 0.5 https://www.galderma.com/pt-pt/sculpting-beauty-by-gain 2024-07-30T15:43:02+00:00 0.5 https://www.galderma.com/es-es/sculpting-beauty-by-gain 2024-07-30T15:39:30+00:00 0.5 https://www.galderma.com/jp-jp/node/3805 2025-03-12T13:49:18+00:00 0.5 https://www.galderma.com/br-pt/solu%C3%A7%C3%B5es-para-skincare-no-inverno 2025-05-30T09:47:49+00:00 0.5 https://www.galderma.com/br-pt/galderma-amplia-fabrica-no-brasil 2025-05-30T09:47:31+00:00 0.5 https://www.galderma.com/br-pt/next-by-galderma 2025-05-30T09:40:53+00:00 0.5 https://www.galderma.com/jp-jp/node/3866 2025-06-06T04:41:28+00:00 0.5 https://www.galderma.com/jp-jp/node/3867 2025-06-06T06:08:32+00:00 0.5 https://www.galderma.com/se-se/cetaphil-6-hour-fast-clear-pimple-patch 2025-10-09T12:21:19+00:00 0.5 https://www.galderma.com/se-se/forsta-spadtaget-for-galdermas 2025-10-09T12:27:37+00:00 0.5 https://www.galderma.com/se-se/galdermas-nya-fabrik-i-uppsala 2025-10-09T12:25:54+00:00 0.5 https://www.galderma.com/jp-jp/node/3914 2026-04-01T07:13:11+00:00 0.5 https://www.galderma.com/jp-jp/node/3961 2026-03-13T09:50:02+00:00 0.5 https://www.galderma.com/jp-jp/node/4069 2026-03-26T09:52:55+00:00 0.5